Literature DB >> 30139807

Understanding FDA-Approved Labeling and CDC Recommendations for Use of Vaccines.

H Cody Meissner1, Karen Farizo2, Douglas Pratt2, Larry K Pickering3, Amanda C Cohn4.   

Abstract

Adherence to recommendations for the use of licensed vaccines ensures maximum individual and societal benefits from the national immunization program. The US Food and Drug Administration (FDA) licenses a vaccine once it determines that data submitted by the manufacturer reveal that the vaccine is safe and effective for its intended use. For each US-licensed vaccine, the FDA-approved prescribing information contains detailed information for health care providers to ensure safe and effective use. Centers for Disease Control and Prevention recommendations for the use of a licensed vaccine often are based on additional considerations, such as disease epidemiology, public acceptance, vaccine supply, and cost. Our objective in this article is to explain the reasons for the differences between FDA-approved prescribing information and Centers for Disease Control and Prevention recommendations for vaccine use.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30139807      PMCID: PMC8988052          DOI: 10.1542/peds.2018-0780

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

1.  Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels.

Authors:  Stanley A Gall; John Myers; Michael Pichichero
Journal:  Am J Obstet Gynecol       Date:  2011-01-26       Impact factor: 8.661

Review 2.  Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC).

Authors:  Faruque Ahmed; Jonathan L Temte; Doug Campos-Outcalt; Holger J Schünemann
Journal:  Vaccine       Date:  2011-08-11       Impact factor: 3.641

3.  General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Andrew T Kroger; William L Atkinson; Edgar K Marcuse; Larry K Pickering
Journal:  MMWR Recomm Rep       Date:  2006-12-01

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-14       Impact factor: 17.586

6.  Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2011-11-25

Review 7.  Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy.

Authors:  Jeffrey N Roberts; Marion F Gruber
Journal:  Vaccine       Date:  2015-01-06       Impact factor: 3.641

8.  Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009.

Authors:  Elizabeth C Briere; Michael Jackson; Shetul G Shah; Amanda C Cohn; Raydel D Anderson; Jessica R MacNeil; Fatima M Coronado; Leonard W Mayer; Thomas A Clark; Nancy E Messonnier
Journal:  Pediatrics       Date:  2012-08-06       Impact factor: 7.124

9.  Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations.

Authors:  Lakshmi Sukumaran; Natalie L McCarthy; Elyse O Kharbanda; Michael M McNeil; Allison L Naleway; Nicola P Klein; Michael L Jackson; Simon J Hambidge; Marlene M Lugg; Rongxia Li; Eric S Weintraub; Robert A Bednarczyk; Jennifer P King; Frank DeStefano; Walter A Orenstein; Saad B Omer
Journal:  JAMA       Date:  2015-10-20       Impact factor: 56.272

10.  Benefits from immunization during the vaccines for children program era - United States, 1994-2013.

Authors:  Cynthia G Whitney; Fangjun Zhou; James Singleton; Anne Schuchat
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-04-25       Impact factor: 17.586

View more
  4 in total

1.  Forgotten, but not forgiven: facing immunization challenges in the 21 st century.

Authors:  Ricardo Palacios
Journal:  Colomb Med (Cali)       Date:  2018-09-30

2.  Evaluation of the decision-making process underlying the initial off-label use of vaccines: a scoping review protocol.

Authors:  Dieynaba Diallo; Caroline Quach
Journal:  BMJ Open       Date:  2021-03-04       Impact factor: 2.692

Review 3.  Understanding Vaccine Safety and the Roles of the FDA and the CDC.

Authors:  H Cody Meissner
Journal:  N Engl J Med       Date:  2022-04-28       Impact factor: 176.079

4.  How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation.

Authors:  Robert M Jacobson; Jennifer L St Sauver; Joan M Griffin; Kathy L MacLaughlin; Lila J Finney Rutten
Journal:  Hum Vaccin Immunother       Date:  2020-04-03       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.